The generation and use of transgenic and gene-targeted mice has become an essential technology for basic cancer research, as well as for other areas of basic biomedical research. Therefore, this facility serves two critical functions within the Cancer Center. First, the Animal Facility provides convenient, affordable and high quality animal care and maintenance to Cancer Center investigators who use transgenic, mutant and other experimental mice in their research. The support for this Facility provided by the Cancer Center, as well as by the University, results in animal maintenance charges that are relatively affordable, which is a prerequisite for genetic studies using large numbers of transgenic and mutant mice. Second, the Facility operates a transgenic and chimeric mouse production service, which allows all Cancer Center investigators to generate new strains of transgenic mice or perform gene targeting (e.g., gene knockout) studies. The Facility provides technical advice on the design and construction of transgenes and gene-targeting vectors. DNA constructs for transgenesis, and genetically modified ES cell lines are produced by individual Cancer Center investigators, then delivered to the facility, where they are injected into mouse eggs or blastocysts, respectively. The resulting mice are then returned to the individual investigators for further analysis and breeding. The Facility also plans to provide cryopreservation of mouse embryos, and to produce new wild type ES cell lines for use by investigators.
| DiCarlo, James E; Mahajan, Vinit B; Tsang, Stephen H (2018) Gene therapy and genome surgery in the retina. J Clin Invest 128:2177-2188 |
| Wert, Katherine J; Velez, Gabriel; Cross, Madeline R et al. (2018) Extracellular superoxide dismutase (SOD3) regulates oxidative stress at the vitreoretinal interface. Free Radic Biol Med 124:408-419 |
| Lee, Andreia; CingÖz, Oya; Sabo, Yosef et al. (2018) Characterization of interaction between Trim28 and YY1 in silencing proviral DNA of Moloney murine leukemia virus. Virology 516:165-175 |
| Schrank, Benjamin R; Aparicio, Tomas; Li, Yinyin et al. (2018) Nuclear ARP2/3 drives DNA break clustering for homology-directed repair. Nature 559:61-66 |
| Proto, Jonathan D; Doran, Amanda C; Gusarova, Galina et al. (2018) Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution. Immunity 49:666-677.e6 |
| Hernandez, Celine; Huebener, Peter; Pradere, Jean-Philippe et al. (2018) HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis. J Clin Invest 128:2436-2451 |
| Lee, Younghyun; Pujol Canadell, Monica; Shuryak, Igor et al. (2018) Candidate protein markers for radiation biodosimetry in the hematopoietically humanized mouse model. Sci Rep 8:13557 |
| Kraakman, Michael J; Liu, Qiongming; Postigo-Fernandez, Jorge et al. (2018) PPAR? deacetylation dissociates thiazolidinedione's metabolic benefits from its adverse effects. J Clin Invest 128:2600-2612 |
| Cui, Xuan; Jauregui, Ruben; Park, Karen Sophia et al. (2018) Multimodal characterization of a novel mutation causing vitamin B6-responsive gyrate atrophy. Ophthalmic Genet 39:512-516 |
| Evans, Lucy P; Newell, Elizabeth A; Mahajan, MaryAnn et al. (2018) Acute vitreoretinal trauma and inflammation after traumatic brain injury in mice. Ann Clin Transl Neurol 5:240-251 |
Showing the most recent 10 out of 331 publications
